Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study
BACKGROUND: Chronic systemic low-grade inflammation in obese subjects is associated with health complications including cardiovascular diseases, insulin resistance and diabetes. Reducing inflammatory responses may reduce these risks. However, available markers of inflammatory status inadequately des...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837611/ https://www.ncbi.nlm.nih.gov/pubmed/20178593 http://dx.doi.org/10.1186/1755-8794-3-5 |
_version_ | 1782178829650886656 |
---|---|
author | van Erk, Marjan J Wopereis, Suzan Rubingh, Carina van Vliet, Trinette Verheij, Elwin Cnubben, Nicole HP Pedersen, Theresa L Newman, John W Smilde, Age K Greef, Jan van der Hendriks, Henk FJ van Ommen, Ben |
author_facet | van Erk, Marjan J Wopereis, Suzan Rubingh, Carina van Vliet, Trinette Verheij, Elwin Cnubben, Nicole HP Pedersen, Theresa L Newman, John W Smilde, Age K Greef, Jan van der Hendriks, Henk FJ van Ommen, Ben |
author_sort | van Erk, Marjan J |
collection | PubMed |
description | BACKGROUND: Chronic systemic low-grade inflammation in obese subjects is associated with health complications including cardiovascular diseases, insulin resistance and diabetes. Reducing inflammatory responses may reduce these risks. However, available markers of inflammatory status inadequately describe the complexity of metabolic responses to mild anti-inflammatory therapy. METHODS: To address this limitation, we used an integrative omics approach to characterize modulation of inflammation in overweight men during an intervention with the non-steroidal anti-inflammatory drug diclofenac. Measured parameters included 80 plasma proteins, >300 plasma metabolites (lipids, free fatty acids, oxylipids and polar compounds) and an array of peripheral blood mononuclear cells (PBMC) gene expression products. These measures were submitted to multivariate and correlation analysis and were used for construction of biological response networks. RESULTS: A panel of genes, proteins and metabolites, including PGE(2 )and TNF-alpha, were identified that describe a diclofenac-response network (68 genes in PBMC, 1 plasma protein and 4 plasma metabolites). Novel candidate markers of inflammatory modulation included PBMC expression of annexin A1 and caspase 8, and the arachidonic acid metabolite 5,6-DHET. CONCLUSION: In this study the integrated analysis of a wide range of parameters allowed the development of a network of markers responding to inflammatory modulation, thereby providing insight into the complex process of inflammation and ways to assess changes in inflammatory status associated with obesity. TRIAL REGISTRATION: The study is registered as NCT00221052 in clinicaltrials.gov database. |
format | Text |
id | pubmed-2837611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28376112010-03-13 Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study van Erk, Marjan J Wopereis, Suzan Rubingh, Carina van Vliet, Trinette Verheij, Elwin Cnubben, Nicole HP Pedersen, Theresa L Newman, John W Smilde, Age K Greef, Jan van der Hendriks, Henk FJ van Ommen, Ben BMC Med Genomics Research article BACKGROUND: Chronic systemic low-grade inflammation in obese subjects is associated with health complications including cardiovascular diseases, insulin resistance and diabetes. Reducing inflammatory responses may reduce these risks. However, available markers of inflammatory status inadequately describe the complexity of metabolic responses to mild anti-inflammatory therapy. METHODS: To address this limitation, we used an integrative omics approach to characterize modulation of inflammation in overweight men during an intervention with the non-steroidal anti-inflammatory drug diclofenac. Measured parameters included 80 plasma proteins, >300 plasma metabolites (lipids, free fatty acids, oxylipids and polar compounds) and an array of peripheral blood mononuclear cells (PBMC) gene expression products. These measures were submitted to multivariate and correlation analysis and were used for construction of biological response networks. RESULTS: A panel of genes, proteins and metabolites, including PGE(2 )and TNF-alpha, were identified that describe a diclofenac-response network (68 genes in PBMC, 1 plasma protein and 4 plasma metabolites). Novel candidate markers of inflammatory modulation included PBMC expression of annexin A1 and caspase 8, and the arachidonic acid metabolite 5,6-DHET. CONCLUSION: In this study the integrated analysis of a wide range of parameters allowed the development of a network of markers responding to inflammatory modulation, thereby providing insight into the complex process of inflammation and ways to assess changes in inflammatory status associated with obesity. TRIAL REGISTRATION: The study is registered as NCT00221052 in clinicaltrials.gov database. BioMed Central 2010-02-23 /pmc/articles/PMC2837611/ /pubmed/20178593 http://dx.doi.org/10.1186/1755-8794-3-5 Text en Copyright ©2010 van Erk et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research article van Erk, Marjan J Wopereis, Suzan Rubingh, Carina van Vliet, Trinette Verheij, Elwin Cnubben, Nicole HP Pedersen, Theresa L Newman, John W Smilde, Age K Greef, Jan van der Hendriks, Henk FJ van Ommen, Ben Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study |
title | Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study |
title_full | Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study |
title_fullStr | Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study |
title_full_unstemmed | Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study |
title_short | Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study |
title_sort | insight in modulation of inflammation in response to diclofenac intervention: a human intervention study |
topic | Research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837611/ https://www.ncbi.nlm.nih.gov/pubmed/20178593 http://dx.doi.org/10.1186/1755-8794-3-5 |
work_keys_str_mv | AT vanerkmarjanj insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT wopereissuzan insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT rubinghcarina insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT vanvliettrinette insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT verheijelwin insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT cnubbennicolehp insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT pedersentheresal insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT newmanjohnw insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT smildeagek insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT greefjanvander insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT hendrikshenkfj insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy AT vanommenben insightinmodulationofinflammationinresponsetodiclofenacinterventionahumaninterventionstudy |